Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
- PMID: 16156851
- DOI: 10.1111/j.1365-2141.2005.05627.x
Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
Abstract
The controlled orchestration of immune responses is a vital feature of cellular immunity in a system that must be able to reliably distinguish self from non-self. Contrary to early beliefs, peptide recognition by T cells exhibits a relatively high level of promiscuity. The requirement for a second signalling event to be present in addition to that provided by T cell receptor ligation for T cell activation to proceed helps to prevent inappropriately directed responses. An expanding array of co-stimulatory or inhibitory signalling receptors and ligands are now recognised to be involved in the control of the crucial decisions made determining the activation, expansion, and effector functions of responding cells, and ultimately the final targeting and execution of these functions. Tight regulation of the temporal and spatial organisation of receptor/ligand expression, combined with both forward and reverse signalling, endows an extraordinary elegance to these co-stimulatory pathways. The immunoglobulin superfamily occupies a central importance in this coordination of immune responses. The understanding of its relevance in a variety of physio-pathological circumstances is now yielding a number of potential targets for therapeutic manipulation, and such immunological molecular adjuvants are beginning to enter clinical trials.
Similar articles
-
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Immunol Rev. 2008. PMID: 18759925 Review.
-
Targeting costimulatory pathways for tumor immunotherapy.Int Rev Immunol. 2007 May-Aug;26(3-4):161-96. doi: 10.1080/08830180701365941. Int Rev Immunol. 2007. PMID: 17558743 Review.
-
Accessory signals for growth and differentiation of human T lymphocytes.Cancer Surv. 1995;22:63-73. Cancer Surv. 1995. PMID: 7720059 Review.
-
Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.Arch Immunol Ther Exp (Warsz). 2008 Sep-Oct;56(5):311-23. doi: 10.1007/s00005-008-0033-2. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18836862 Review.
-
The T-body approach: redirecting T cells with antibody specificity.Handb Exp Pharmacol. 2008;(181):329-42. doi: 10.1007/978-3-540-73259-4_14. Handb Exp Pharmacol. 2008. PMID: 18071952 Review.
Cited by
-
Modification of accessory molecule signaling.Springer Semin Immunopathol. 2006 Jun;27(4):409-24. doi: 10.1007/s00281-006-0018-3. Epub 2006 May 16. Springer Semin Immunopathol. 2006. PMID: 16738953 Review.
-
Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients.Kidney Int Rep. 2019 Dec 7;5(2):149-158. doi: 10.1016/j.ekir.2019.11.015. eCollection 2020 Feb. Kidney Int Rep. 2019. PMID: 32043028 Free PMC article.
-
Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity.J Steroid Biochem Mol Biol. 2015 Jul;151:3-11. doi: 10.1016/j.jsbmb.2014.09.010. Epub 2014 Sep 12. J Steroid Biochem Mol Biol. 2015. PMID: 25218442 Free PMC article. Review.
-
Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.Int J Hematol. 2016 May;103(5):545-53. doi: 10.1007/s12185-016-1964-8. Epub 2016 Mar 11. Int J Hematol. 2016. PMID: 26968550
-
Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia.J Immunol Res. 2020 Feb 17;2020:4098235. doi: 10.1155/2020/4098235. eCollection 2020. J Immunol Res. 2020. PMID: 32149157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources